Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Aug 30:2015:bcr2015210034.
doi: 10.1136/bcr-2015-210034.

Successful immunoadsorption of life-threatening bleeding in factor VIII inhibitor disease, but no long-term remission with anti-CD20 treatment

Florian Grahammer  1 , Karl-Georg Fischer  1
Affiliations
Case Reports

Successful immunoadsorption of life-threatening bleeding in factor VIII inhibitor disease, but no long-term remission with anti-CD20 treatment

Florian Grahammer et al. BMJ Case Rep. .

Abstract

A 62-year-old man and a 64-year-old woman presented to our institution with acquired haemophilia A. They both developed life-threatening bleeding. Immunoadsorption using protein A columns was used to rapidly lower factor VIII inhibitor levels. Immunosuppression with steroids and the anti-CD20 antibody, rituximab, was instituted. Yet their effects were either partial or complicated by an early relapse. Repetitive cyclophosphamide administration led to a sustained immunological response. While immunoadsorption appears effective and safe to lower factor VIII inhibitor levels, it seems that further preferably randomised controlled trials are needed to establish the value of rituximab versus the standard immunosuppressive regime comprising cyclophosphamide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Decisive laboratory parameters and treatments for patient A and patient B. The symbols in the figure mark the following events: ▪ course of PTT values in s; ▴ course of inhibitor level in Bethesda Units (BU)/mL; ○ course of factor VIII level in % of normal; formula image administration of rituximab; formula image immunoadsorption treatment.
See this image and copyright information in PMC

References

    1. Franchini M, Gandini G, Di Paolantonio T et al. . Acquired hemophilia A: a concise review. Am J Hematol 2005;80:55–63. 10.1002/ajh.20390 - DOI - PubMed
    1. Arai M, Scandella D, Hoyer LW. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J Clin Invest 1989;83:1978–84. 10.1172/JCI114107 - DOI - PMC - PubMed
    1. Cohen AJ, Kessler CM. Acquired inhibitors. Bailleres Clin Haematol 1996;9:331–54. 10.1016/S0950-3536(96)80067-9 - DOI - PubMed
    1. Bouvry P, Recloux P. Acquired hemophilia. Haematologica 1994;79:550–6. - PubMed
    1. Hay CRM. Acquired hemophilia. Bailleres Clin Haematol 1998;11:287–303. 10.1016/S0950-3536(98)80049-8 - DOI - PubMed

Publication types